.Pharmacolibrary.Drugs.ATC.J.J05AP04 .Pharmacolibrary.Drugs.ATC.J.J05AP04| name: | Faldaprevir |
| ATC code: | J05AP04 | route: | oral |
| n-compartments | 2 |
Faldaprevir is a protease inhibitor developed as an antiviral agent for the treatment of chronic hepatitis C virus (HCV) infection. It inhibits the HCV NS3/4A protease, a key enzyme in the viral replication process. Faldaprevir was investigated in clinical trials but has not been approved or marketed due to cessation of its development.
Pharmacokinetic parameters observed in healthy adult volunteers after oral administration.